Nathan D. Wong

picture of Nathan D. Wong

School of Medicine

Director, UCI Heart Disease Prevention Program (Preventive Cardiology)
School of Medicine

Professor, Department of, Epidemiology
School of Medicine

Public Health

PH.D., Yale University, 1987
M.P.H., Yale University, 1985

Phone: (949) 824-5561

University of California, Irvine
Heart Disease Prevention Program
Division of Cardiology, C240 Medical Sciences 1
University of California
Mail Code: 4079
Irvine, CA 92697
Research Interests
Epidemiology, prevention, coronary calcium, diabetes, cardiovascular diseases
Academic Distinctions
Academician, Academy of Arts and Sciences, Republic of Sprska, Bosnia and Herzegovina, 2013
Full Professor, European Center for Peace and Development (formed by the United Nations), 2017
Research Abstract
General Research Interests:

My research has focused on three major areas in cardiovascular epidemiology and prevention:

1) Epidemiology and prognosis of diabetes and cardiovascular disease, including cardiovascular risk factor control in diabetes

2) coronary evaluated by computed tomography and other subclinical measures of atherosclerosis and their epidemiology (including relation to diabetes and metabolic syndrome) and prognosis

3) Evaluation and predictors of residual cardiovascular disease risk, including dyslipidemia, hypertension, and cardiac biomarkers in population-based studies and registries
Awards and Honors
Who’s Who in America, 2006-
Who’s Who in the World, 2007-
Research Mentor Award, Division of Cardiology, UC Irvine, 2008
Jan Kellerman Memorial Award for Achievement in Preventive Cardiology, 2011
Distinguished Fellowship Award of the International Academy of Cardiology, 2013
Honorary Member, Academy of Nutrition and Dietetics, 2014
Albert Nelson Marquis Lifetime Achievement Award, 2020
Short Biography

Dr. Nathan Wong is a cardiovascular epidemiologist, specialist in preventive cardiology, and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine in California, with joint appointments in Epidemiology and UCLA and UC Irvine. He holds MPH and PhD degrees in epidemiology from Yale University and is a fellow of the American College of Cardiology, American Heart Association, National Lipid Association, and American Society for Preventive Cardiology He is a past president of the American Society for Preventive Cardiology and Pacific Lipid Association (Chapter of the National Lipid Association), and president-elect of the Interamerican Heart Foundation. In addition, he recently served as chair of the Diabetes Collaborative Registry Research and Publications Committee and is editor of the ACC Diabetes and Cardiometabolic Clinical Topic Collection. Dr. Wong is also an honorary member of the Academy of Nutrition and Dietetics, Academician of the Republic of Srpska (Bosnia and Herzegovina) Academy of Sciences and Arts and Full Professor of the European Center for Peace and Development. He is also a recipient of the Jan Kellerman Memorial Award for Achievement in Preventive Cardiology and Distinguished Fellowship Award of the International Academy of Cardiology, and is listed in Who’s Who in America and Who’s Who in the World. He is a recent recipient of the Albert Nelson Marquis Lifetime Achievement Award.

Dr. Wong has primary research interests in the epidemiology of subclinical atherosclerosis, including vascular calcification, as well as lipid and diabetes management, and has authored over 350 papers and co-edited seven textbooks, including the Braunwald Companion on Preventive Cardiology and two editions of the ASPC Manual on Preventive Cardiology. He is also on the editorial board of several cardiology and diabetes-related journals. Dr. Wong lectures locally, nationally and internationally on various topics in preventive cardiology.
Wong ND, Glovaci D, Wong K, Malik S, Franklin SS, Wygant G, Iloeje U. Global Cardiovascular Disease Risk Assessment in United States Adults with Diabetes. Diab Vas Disease Res 2012; 9: 146-152.
Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 2014; 11: 276-89.
Budoff MJ, Young R, Lopez VA, Kronmal RA, Nasir K, Blumenthal RS, Detrano RC, Bild DE, Guerci AD, Liu K, Shea S, Szklo M, Post W, Lima J, Bertoni A, Wong ND. Progression of Coronary Calcium and Incident Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2013; 61: 1231-1239.
Tang L, Patao C, Luo Y, Wong ND. Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons with Coronary Heart Disease (From the National Health and Nutrition Examination Survey 2007-2010). Am J Cardiol 2013; 112: 1126-32.
Wong ND, Dede J, Chow VH, Wong KS, Franklin SS. Global Cardiovascular Risk Associated with Hypertension and Extent of Treatment and Control According to Risk Group. Am J Hypertens 2012; 25: 561-7.
Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, Szklo M, Barr RG, Wong ND. Impact of subclinical atherosclerosis on cardiovascular disease events in persons with metabolic syndrome and diabetes: the Multiethnic Study of Atherosclerosis. Diabetes Care 2011; 34: 2285-90.
Wong ND, Wilson PWF, Kannel WB. Serum cholesterol as a risk factor post-myocardial infarction: the Framingham Study. Ann Intern Med 1991: 115: 687-93.
Wong ND, Kowabunpat D, Vo A, Detrano R, Eisenberg H, Goel M, Tobis JM. Coronary calcium in asymptomatic men and women: relation to age and risk factors. Am Heart J 1994; 127: 422-30.
Wong ND, Detrano RC, Diamond G, Rezayat C, Mahmoudi R, Chong C, Tang W, Puentes G, Kang X, Abrahamson D. Does coronary artery screening by electron beam computed tomography motivate healthy lifestyle behaviors? Am J Cardiol 1996; 78: 1220-3.
Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-360.
Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography: relation to new cardiovascular events. Am J Cardiol 2000; 86: 495-98.
Wong ND, Sciammarella M, Miranda-Peats R, Whitcomb B, Gallagher A, Hachamovich R, Friedman J, Hayes S, Berman DS. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003; 41: 1547-53
Wong ND, Kawakubo M, LaBree L, Azen S, Xiang M, Zhuang N, Detrano R. Control of lipids according to National Cholesterol Education Program (NCEP) criteria and coronary calcium progression. Am J Cardiol 2004; 94: 431-436.
Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams R. The impact of the metabolic syndrome and diabetes on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
Wong ND, Rozanski AR, Gransar H, Dalbeck J, Miranda-Peats R, Hayes S, Shaw L, Friedman J, Polk D, Berman DS. Metabolic syndrome increases the likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 2005; 28: 1445-50.
Wong ND, Lopez V, Tang S, Williams GR. Prevalence, treatment and control of combined hypertension and hypercholesterolemia in adults in the USA. Am J Cardiol 2006; 98: 204-208.
Wong ND, Lopez VA, L’Italien G, Chen R, Kline S, Franklin SS. High prevalence and treatment rates, but inadequate control of hypertension in U.S. persons in 2003-2004 with cardiovascular disease comorbidities. Arch Intern Med 2007; 167 (22): 2437-42.
Wong ND. Metabolic syndrome: cardiovascular risk assessment and management. Am J Cardiovasc Drugs 2007;7:259-72.
Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of near-tern coronary heart disease events in major American ethnic groups: the Multiethnic Study of Atherosclerosis (MESA). N Engl J Med 2008; 358: 1336-45.
Hoang K, Ghandehari H, Lopez VA, Barboza MG, Wong ND. Global coronary heart disease risk assessment of U.S. Persons with the metabolic sydnrome. Diabetes Care 2008; 31: 1405-9.
Professional Societies
Fellow, American College of Cardiology
Fellow, American Heart Association Council on Epidemiology and Prevention
Fellow, National Lipid Assocation
Fellow, American Society for Preventive Cardiology
Other Experience
Past President
American Society for Preventive Cardiology 2010—2012

Pacific Lipid Association 2018—2019

Interamerican Heart Foundation 2019—2021

Past Chair
American Heart Assocation Prevention Science Subcommittee

Diabetes Collaborative Registry Research and Publications Committee 2018—pres

Graduate Programs

Research Center
Heart Disease Prevention Program
Last updated